36734072|t|The molecular mechanism of gamma-aminobutyric acid against AD: the role of CEBPalpha/circAPLP2/miR-671-5p in regulating CNTN1/2 expression.
36734072|a|The expression levels of the synaptic-related proteins contactin 1/2 (CNTN1/2) are down-regulated in the brain of Alzheimer's disease (AD), but the mechanism has not been clarified. gamma-Aminobutyric acid (GABA) is considered a biologically active ingredient in food. Our previous research revealed that GABA can regulate CEBPalpha expression in Abeta-treated U251 cells. However, it is uncertain whether GABA can antagonize the pathogenesis of AD. Whether GABA can inhibit the reduction in CNTN1/2 expression by regulating CEBPalpha/circAPLP2/miR-671-5p in the AD brain remains unclear yet. Here, we demonstrate that GABA could attenuate the deposition of Abeta in the brain and ameliorate cognitive impairments in AD model mice. The expressions of CEBPalpha, circAPLP2, and CNTN1/2 were decreased and that of miR-671-5p was increased in AD model mouse brains and Abeta-induced SH-SY5Y cells. These alterations were partly reversed by GABA. The CNTN1/2 expression was down-regulated and up-regulated in SH-SY5Y cells treated with miR-671-5p mimics and miR-671-5p inhibitors, respectively. The results from the luciferase reporter assay revealed that miR-671-5p could bind to the 3'-untranslated region of circAPLP2. The silencing of circAPLP2 with the siRNA duplex caused an up-regulation of miR-671-5p and a down-regulation of CNTN1/2 in SH-SY5Y cells. The silencing of CEBPalpha with the siRNA duplex caused a down-regulation of circAPLP2 or CNTN1/2 and an up-regulation of miR-671-5p. In conclusion, GABA may decrease the deposition of Abeta in the brain, inhibit the down-regulation of CNTN1/2 expression, and ameliorate the cognitive deficits of AD model mice. The CEBPalpha/circAPLP2/miR-671-5p pathway plays a role in regulating CNTN1/2 expression by GABA in AD.
36734072	27	50	gamma-aminobutyric acid	Chemical	MESH:D005680
36734072	59	61	AD	Disease	MESH:D000544
36734072	75	84	CEBPalpha	Gene	1050
36734072	95	105	miR-671-5p	Gene	102465990
36734072	120	127	CNTN1/2	Gene	1272;6900
36734072	195	208	contactin 1/2	Gene	1272;6900
36734072	210	217	CNTN1/2	Gene	1272;6900
36734072	254	273	Alzheimer's disease	Disease	MESH:D000544
36734072	275	277	AD	Disease	MESH:D000544
36734072	322	345	gamma-Aminobutyric acid	Chemical	MESH:D005680
36734072	347	351	GABA	Chemical	MESH:D005680
36734072	445	449	GABA	Chemical	MESH:D005680
36734072	463	472	CEBPalpha	Gene	1050
36734072	487	492	Abeta	Gene	14961
36734072	501	505	U251	CellLine	CVCL:0021
36734072	546	550	GABA	Chemical	MESH:D005680
36734072	586	588	AD	Disease	MESH:D000544
36734072	598	602	GABA	Chemical	MESH:D005680
36734072	632	639	CNTN1/2	Gene	1272;6900
36734072	665	674	CEBPalpha	Gene	1050
36734072	685	695	miR-671-5p	Gene	102465990
36734072	703	705	AD	Disease	MESH:D000544
36734072	759	763	GABA	Chemical	MESH:D005680
36734072	798	803	Abeta	Gene	14961
36734072	832	853	cognitive impairments	Disease	MESH:D003072
36734072	857	859	AD	Disease	MESH:D000544
36734072	866	870	mice	Species	10090
36734072	891	900	CEBPalpha	Gene	1050
36734072	917	924	CNTN1/2	Gene	1272;6900
36734072	952	962	miR-671-5p	Gene	102465990
36734072	980	982	AD	Disease	MESH:D000544
36734072	989	994	mouse	Species	10090
36734072	1006	1011	Abeta	Gene	14961
36734072	1020	1027	SH-SY5Y	CellLine	CVCL:0019
36734072	1077	1081	GABA	Chemical	MESH:D005680
36734072	1087	1094	CNTN1/2	Gene	1272;6900
36734072	1145	1152	SH-SY5Y	CellLine	CVCL:0019
36734072	1172	1182	miR-671-5p	Gene	102465990
36734072	1194	1204	miR-671-5p	Gene	102465990
36734072	1292	1302	miR-671-5p	Gene	102465990
36734072	1434	1444	miR-671-5p	Gene	102465990
36734072	1470	1477	CNTN1/2	Gene	1272;6900
36734072	1481	1488	SH-SY5Y	CellLine	CVCL:0019
36734072	1513	1522	CEBPalpha	Gene	1050
36734072	1586	1593	CNTN1/2	Gene	1272;6900
36734072	1618	1628	miR-671-5p	Gene	102465990
36734072	1645	1649	GABA	Chemical	MESH:D005680
36734072	1681	1686	Abeta	Gene	14961
36734072	1732	1739	CNTN1/2	Gene	12805;21367
36734072	1771	1789	cognitive deficits	Disease	MESH:D003072
36734072	1793	1795	AD	Disease	MESH:D000544
36734072	1802	1806	mice	Species	10090
36734072	1812	1821	CEBPalpha	Gene	1050
36734072	1832	1842	miR-671-5p	Gene	102465990
36734072	1878	1885	CNTN1/2	Gene	1272;6900
36734072	1900	1904	GABA	Chemical	MESH:D005680
36734072	1908	1910	AD	Disease	MESH:D000544
36734072	Negative_Correlation	MESH:D005680	MESH:D000544
36734072	Association	1050	6900
36734072	Negative_Correlation	1050	14961
36734072	Association	1050	1272
36734072	Negative_Correlation	MESH:D000544	6900
36734072	Positive_Correlation	MESH:D005680	102465990
36734072	Negative_Correlation	MESH:D005680	1272
36734072	Negative_Correlation	MESH:D005680	MESH:D003072
36734072	Negative_Correlation	MESH:D005680	14961
36734072	Negative_Correlation	MESH:D000544	1050
36734072	Positive_Correlation	102465990	6900
36734072	Negative_Correlation	MESH:D005680	21367
36734072	Positive_Correlation	MESH:D000544	102465990
36734072	Negative_Correlation	MESH:D005680	6900
36734072	Positive_Correlation	MESH:D005680	1050
36734072	Negative_Correlation	MESH:D000544	1272
36734072	Positive_Correlation	102465990	1272
36734072	Association	102465990	14961
36734072	Negative_Correlation	MESH:D005680	12805

